Press "esc" to clear
Go to Advanced Search

Showing results

110 of 436

Article ID: 694781

Mayo Clinic identifica posible alternativa terapéutica para cáncer de mama triple negativo

Mayo Clinic

Un fármaco utilizado en el cáncer sanguíneo puede resultar útil en el cáncer de mama triple negativo, descubrieron los investigadores de Mayo Clinic. El cáncer de mama triple negativo es uno de los tipos más agresivos y letales de cáncer de mama. El estudio se publicó en la Revista de Investigación Clínica.

Released:
17-May-2018 4:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 649790

Inside Cancer Cells, Tumor Growth in Kidney Cancer, Genetic Screening Guidelines, and More in the Cancer News Source

Newswise

Click here to go directly to the Cancer News Source

Released:
11-May-2018 3:15 PM EDT
EXPERT AVAILABLE
Open in New Tab Add to Favorites
Comment
tumorforarticlecolorized.jpg

Article ID: 694156

Device Captures Vesicles Shed by Brain Tumors, Offering Patient-Specific Diagnosis and Treatment

National Institute of Biomedical Imaging and Bioengineering

Bioengineers have developed micro-technologies that capture extracellular vesicles (EVs) released by brain tumors. The vesicles carry samples of the mutated genetic material and proteins causing malignancy that researchers can analyze to optimize precision cancer treatment.

Released:
8-May-2018 11:25 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 693960

Pitt and UPMC join NIH in Launching Nationwide Precision Medicine Effort

Health Sciences at the University of Pittsburgh

On May 6, the National Institutes of Health will open national enrollment for the All of Us Research Program in collaboration the University of Pittsburgh and other partners.

Released:
3-May-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 693861

Mayo Clinic将和美国国立卫生研究院(NIH)一起启动名为 “我们所有人” 的研究计划 (All of Us Research Program)

Mayo Clinic

明尼苏达州罗切斯特 – 5月6日美国国立卫生研究院将开放 “我们所有人”研究计划的全国注册。 根据国立卫生研究院的资讯,这项计划旨在推动具有各种不同背景的所有人的个人化预防,治疗和护理。

Released:
2-May-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 693828

Mayo Clinic se une a los Institutos Nacionales de Salud para iniciar el programa de investigación “Todos nosotros”

Mayo Clinic

El 6 de mayo próximo, los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) abrirán las inscripciones en todo el país para el programa de investigación “Todos nosotros”.

Released:
1-May-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 693817

Mayo Clinic joins NIH in launching All of Us Research Program

Mayo Clinic

On May 6, the National Institutes of Health (NIH) will open national enrollment for the All of Us Research Program. According to the NIH the program is a momentous effort to advance individualized prevention, treatment and care for people of all backgrounds.

Released:
1-May-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
AllofUs_Ohno-Machado.jpg

Article ID: 693797

Join All of Us: California Researchers Call for Volunteers as NIH’s Landmark Precision Medicine Research Effort Launches Nationwide

University of California San Diego Health

The All of Us Research Program officially opens for enrollment Sunday, May 6. Led by the National Institutes of Health (NIH), All of Us is an unprecedented effort to gather genetic, biological, environmental, health and lifestyle data from 1 million or more volunteer participants living in the United States. A major component of the federal Precision Medicine Initiative, the program’s ultimate goal is to accelerate research and improve health.

Released:
1-May-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    30-Apr-2018 11:00 AM EDT

Article ID: 693613

Genomic Analysis Unravels Complexities of the Most Common Form of Lymphoma and Enables Personalized Treatment

Dana-Farber Cancer Institute

The majority of patients with diffuse large B cell lymphoma (DLBCL) can be treated effectively. However, people whose disease recurs face a shortage of good options, especially because the disease is driven by a complicated mix of genetic alterations. Genomic analysis by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard now offers a better framework for understanding the disease’s many forms, which will help to predict individual patient outcomes and guide personalized treatment.

Released:
26-Apr-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ChenBrain.jpg
  • Embargo expired:
    26-Apr-2018 5:00 AM EDT

Article ID: 693499

Noninvasive Brain Tumor Biopsy on the Horizon

Washington University in St. Louis

Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.

Released:
26-Apr-2018 5:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 436





Chat now!